The New York Times thinks a blockchain could help stamp out fake news

Blockchain technology is at the core of a new research project the New York Times has launched, aimed at making “the origins of journalistic content clearer to [its] audience.”
The news: The Times has launched what it calls The News Provenance Project, which will experiment with ways to combat misinformation in the news media. The first project will focus on using a blockchain—specifically a platform designed by IBM—to prove that photos are authentic.
Blockchain? Really? Rumors and speculation swirled in March, after CoinDesk reported that the New York Times was looking for someone to help it develop a “blockchain-based proof-of-concept for news publishers.” Though the newspaper removed the job posting after the article came out, apparently it was serious. In a new blog post, project lead Sasha Koren explains that by using a blockchain, “we might in theory provide audiences with a way to determine the source of a photo, or whether it had been edited after it was published.”
Unfulfilled promise: Using a blockchain to prove the authenticity of journalistic content has long been considered a potential application of the technology, but attempts to do it so far haven’t gotten much traction. If the New York Times can develop a compelling application, it has enough influence to change that.
Keep Reading
Most Popular

Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.